Pfizer seeks FDA approval of COVID-19 boosters for children ages 5 to 11
Getting ahead of head and neck cancer
28 April 2022Neural pathway key to sensation of pleasant touch identified
28 April 2022Pfizer seeks FDA approval of COVID-19 boosters for children ages 5 to 11
Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years.
